These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31744260)

  • 21. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.
    Chan BK; Sistrom M; Wertz JE; Kortright KE; Narayan D; Turner PE
    Sci Rep; 2016 May; 6():26717. PubMed ID: 27225966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P22 Phage Shows Promising Antibacterial Activity under Pathophysiological Conditions.
    Gildea L; Ayariga JA; Robertson BK; Villafane R
    Arch Microbiol Immunol; 2022; 6(1):81-100. PubMed ID: 35996377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli.
    Rahmani R; Zarrini G; Sheikhzadeh F; Aghamohammadzadeh N
    Jundishapur J Microbiol; 2015 Feb; 8(2):e17744. PubMed ID: 25834712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different approaches for using bacteriophages against antibiotic-resistant bacteria.
    Yosef I; Kiro R; Molshanski-Mor S; Edgar R; Qimron U
    Bacteriophage; 2014 Jan; 4(1):e28491. PubMed ID: 24653944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phages for Africa: The Potential Benefit and Challenges of Phage Therapy for the Livestock Sector in Sub-Saharan Africa.
    Makumi A; Mhone AL; Odaba J; Guantai L; Svitek N
    Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage therapy in children: facts and prospects.
    Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophages as antimicrobial agents against major pathogens in swine: a review.
    Zhang J; Li Z; Cao Z; Wang L; Li X; Li S; Xu Y
    J Anim Sci Biotechnol; 2015; 6(1):39. PubMed ID: 26309734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria.
    Weynberg KD; Jaschke PR
    Phage (New Rochelle); 2020 Mar; 1(1):23-26. PubMed ID: 36147618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a Novel Lytic Podoviridae Phage Pu20 for Biological Control of Drug-Resistant
    Zhang Y; Ding Y; Li W; Zhu W; Wang J; Wang X
    Pathogens; 2021 Jan; 10(1):. PubMed ID: 33406779
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic and Chemical Engineering of Phages for Controlling Multidrug-Resistant Bacteria.
    Guo D; Chen J; Zhao X; Luo Y; Jin M; Fan F; Park C; Yang X; Sun C; Yan J; Chen W; Liu Z
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33669513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete genome sequence of new bacteriophage phiE142, which causes simultaneously lysis of multidrug-resistant
    Amarillas L; Chaidez C; González-Robles A; León-Félix J
    Stand Genomic Sci; 2016; 11():89. PubMed ID: 27999624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriophage and their lysins for elimination of infectious bacteria.
    O'Flaherty S; Ross RP; Coffey A
    FEMS Microbiol Rev; 2009 Jul; 33(4):801-19. PubMed ID: 19416364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified Bacteriophage Tail Fiber Proteins for Labeling, Immobilization, Capture, and Detection of Bacteria.
    Dunne M; Loessner MJ
    Methods Mol Biol; 2019; 1918():67-86. PubMed ID: 30580400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of bacteriophages for detection and control of foodborne pathogens.
    Hagens S; Loessner MJ
    Appl Microbiol Biotechnol; 2007 Sep; 76(3):513-9. PubMed ID: 17554535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.